These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8373527)

  • 1. Vaccine delivery systems: potential methods for use in antifertility vaccines.
    Stevens VC
    Am J Reprod Immunol; 1993 Apr; 29(3):176-88. PubMed ID: 8373527
    [No Abstract]   [Full Text] [Related]  

  • 2. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). III. Evaluation of various vehicles and adjuvants.
    Chang CC; Tsong YY; Nash HA
    J Reprod Immunol; 1985 Feb; 7(2):163-9. PubMed ID: 3981489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). I. Alternative macromolecular carriers.
    Tsong YY; Chang CC; Nash HA
    J Reprod Immunol; 1985 Feb; 7(2):139-49. PubMed ID: 3981487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). II. Use of compounds of the muramyl dipeptide (MDP) family as adjuvants.
    Nash HA; Chang CC; Tsong YY
    J Reprod Immunol; 1985 Feb; 7(2):151-62. PubMed ID: 3981488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential anti-pregnancy vaccine built by conjugation of the beta-subunit of human chorionic gonadotropin to adjuvant-active muramyl peptide.
    Schutze MP; LeClerc C; Jolivet M; Deriaud E; Audibert F; Chang CC; Chedid L
    Am J Reprod Immunol Microbiol; 1987 Jul; 14(3):84-90. PubMed ID: 2445212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). IV. The role of adjuvants in booster injections.
    Chang CC; Nash HA; Tsong YY
    J Reprod Immunol; 1986 Dec; 9(4):327-37. PubMed ID: 2434651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the development of human chorionic gonadotropin antifertility vaccines.
    Stevens VC
    Am J Reprod Immunol; 1996 Mar; 35(3):148-55. PubMed ID: 8962640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in antifertility vaccine research.
    Covey DC; O'Brien KD; Moore DE
    West J Med; 1985 Feb; 142(2):197-202. PubMed ID: 3892913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable delivery system for a birth control vaccine: immunogenicity studies in rats and monkeys.
    Singh M; Singh O; Talwar GP
    Pharm Res; 1995 Nov; 12(11):1796-800. PubMed ID: 8592689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in immunocontraception.
    Talwar GP; Gaur A
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1075-8. PubMed ID: 2445210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic control of fertility: search for a contraceptive vaccine.
    Gillett PG
    Clin Obstet Gynecol; 1977 Sep; 20(3):705-15. PubMed ID: 891062
    [No Abstract]   [Full Text] [Related]  

  • 12. The WHO Task Force on Vaccines for Fertility Regulation. Its formation, objectives and research activities.
    Griffin PD
    Hum Reprod; 1991 Jan; 6(1):166-72. PubMed ID: 1874951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine against pregnancy: roundup on world research.
    Fam Plann Perspect; 1976; 8(2):77-9. PubMed ID: 817933
    [No Abstract]   [Full Text] [Related]  

  • 14. Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.
    Badiee A; Heravi Shargh V; Khamesipour A; Jaafari MR
    Vaccine; 2013 Jan; 31(5):735-49. PubMed ID: 23219436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controversial contraception: immunization against human chorionic gonadotropin].
    van Kammen JR
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1326-7. PubMed ID: 8710014
    [No Abstract]   [Full Text] [Related]  

  • 16. Cationic liposomes as vaccine adjuvants.
    Christensen D; Korsholm KS; Andersen P; Agger EM
    Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid.
    Nash H; Johansson ED; Talwar GP; Vasquez J; Segal S; Coutinho E; Luukkainen T; Sundaram K
    Fertil Steril; 1980 Oct; 34(4):328-35. PubMed ID: 7418885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity trial of a contraceptive vaccine based on human chorionic gonadotropin.
    Manning PA
    Vaccine; 1986 Dec; 4(4):271. PubMed ID: 3799021
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent developments in particulate-based vaccines.
    Perrie Y; Kirby D; Bramwell VW; Mohammed AR
    Recent Pat Drug Deliv Formul; 2007; 1(2):117-29. PubMed ID: 19075879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for contraceptive vaccines in fertility control?
    Rao AJ
    J Biosci; 2001 Nov; 26(4 Suppl):425-7. PubMed ID: 11779957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.